论文部分内容阅读
目的通过对住院病历的医嘱点评,对我院亚硫酸氢钠甲萘醌注射液的用药现状进行统计分析,并提出合理化的改进措施。方法选取2014年1~6月医院亚硫酸氢钠甲萘醌注射液使用部门进行统计,取使用频率较高的科室排序前3名的数据进行统计分析。结果临床采用亚硫酸氢钠甲萘醌注射液静脉滴注给药存在超剂量和给药途径不适宜等超说明书使用现象,静脉滴注给药中也未采取任何避光措施,加大了亚硫酸氢钠甲萘醌注射液临床使用的风险。结论医院药事管理与药物治疗学委员会和医务部门采取措施,停止亚硫酸氢钠甲萘醌注射液临床静脉滴注给药用法,严格按照药品说明书规定的适应证和用法用量使用,加强用药监护,降低严重药品不良反应的发生,保障用药安全。
OBJECTIVE To make a statistical analysis on the present situation of medication of mefenadine sodium bisulfite injection in our hospital by referring to the doctor’s advice of inpatient medical records and to propose rational measures for improvement. Methods From January to June 2014, the hospital department of menadine sodium bisulfite injection was used for statistical analysis, and the data of the top 3 departments ranked by the higher frequency of use were statistically analyzed. Results The clinical use of sodium bisulfite menadione injection intravenous infusion of overdosage and administration of inappropriate instructions such as the use of ultra-instructions, intravenous drip medication did not take any dark measures to increase the Asian Risk of clinical use of sodium naproxen sodium injection. Conclusion The hospital pharmacy management and medicine treatment committee and the medical department take measures to stop the clinical application of sodium bisulfite menaquinone intravenous infusion, in strict accordance with the indications and usage of drugs specification to use, to strengthen the use of drugs Guardianship and reduce the incidence of serious adverse drug reactions, to ensure drug safety.